Montpellier, France, Novembre 18th 2022 – Hospices Civils de Lyon (HCL), France, have aquired Epione®, the robotic platform developed by Quantum Surgical (QS) that is designed to enable minimally invasive ablations of tumors in the abdomen. HCL ranks as France’s second largest university hospital centre. This partnership between HCL and QS will allow more patients to benefit from Epione®, an innovative platform allowing clinicians to plan, target, deliver and confirm ablation treatment in a more secure and precise manner. Epione® is currently used to target liver and kidney tumors but will be expanded to the treatment of lungs and bones as the Radiologists at HCL expand their robotic interventional oncology practice.
HCL is the second hospital in the world to offer this groundbreaking platform. The first Epione® robot was acquired by Institut Gustave Roussy (France) in January 2022 and the team is approaching their 100th robotic procedure.
“This new acquisition of Epione® is a major step for QS and a full validation of the key benefits that Epione® offers. It is a great honor to have our robotic system acquired by one of the top medical institutions in France. The most exciting part of this story is that patients will now have a powerful new technology that can offer curative treatments by robotically navigating to destroy tumors while sparing surrounding healthy tissue”, explains Bertin Nahum, QS CEO.
“Epione® is a unique percutaneous robotic solution […] Currently, only few expert radiologists perform these treatments. Robotics will allow to standardize these treatments and more radiologists will thus be able to perform these cases, especially the more complex ones, on tumors that would not be treated . This will allow us to help and cure more patients”, underlines Pr. Laurent Milot, deputy Head of Medical and Interventional imaging Department at HCL.
On the 27th of last October, QS was awarded prestigious Prix Galien USA 2022, in the medtech start-up category, for its Epione® robotic platform.
About Quantum Surgical
Quantum Surgical is a leading French medtech company in healthcare innovation. It develops intelligent solutions capable of responding to complex and widespread medical challenges. Its Epione® robotic platform for percutaneous ablation is dedicated to the curative and early treatment of cancers. It is currently the only robotic platform capable of assisting practitioners in planning, targeting and performing percutaneous ablation procedures on cancerous tumours, particularly those located in the abdomen. Quantum Surgical thus offers a new approach to cancer treatment by enabling standardisation of care, and therefore more patients will benefit from innovative, better targeted and less aggressive treatments.
Co-founded in 2017 by Bertin Nahum, it is based in Montpellier, in the Occitanie region, and has an international reach.
For more information, please visit Quantum Surgical and follow our LinkedIn and Twitter accounts.
